Bayforest Capital’s Zimmer Biomet ZBH Stock Holding History

Bayforest Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-834	Closed	-$75K	–	1111
2025 Q4	$75K	Sell	834 -1,063	-56%	-$101K	0.06%	528
2025 Q3	$187K	Buy	+1,897	New	+$188K	0.09%	399

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayforest Capital's ZBH Position: Q1 2026 in Review

Bayforest Capital sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 834 shares — an estimated $75K sold.

Bayforest Capital first reported a position in ZBH in Q3 2025 and held it in 2 quarters. The position peaked at $187K in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Bayforest Capital reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Bayforest Capital sold 834 Zimmer Biomet shares in Q1 2026, an estimated $75K.
Bayforest Capital first reported a position in Zimmer Biomet in Q3 2025 and held it in 2 quarters.
Bayforest Capital's Zimmer Biomet position peaked at $187K in Q3 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.